IL2 and lobular neoplasia: Administration of human IL-2 in refractory LN patients reported that most patients had reduced proteinuria, along with decreased urine erythrocytes and anti-dsDNA production, elevated expression of C3 and C4, and high percentage of Treg cells (151).